Parameters | Group | Baseline | Week3 | Week6 |
---|---|---|---|---|
Inflammatory markers | ||||
 IL-1 (pg/mL) | Control | 100.03 ± 1.76 Aa | 97.44 ± 2.05 Aa | 97.92 ± 1.26 Aa |
EWN | 97.07 ± 0.83 Aa | 96.5 ± 1.71 Aa | 96.32 ± 1.53 Aa | |
 IL-6 (pg/mL) | Control | 32.59 ± 0.62 Aa | 30.38 ± 0.60 Aa | 32.43 ± 0.70 Aa |
EWN | 31.35 ± 0.32 Aa | 30.17 ± 0.38 Ab | 32.39 ± 0.39 Aa | |
 TNF-α (pg/mL) | Control | 97.16 ± 2.35 Aa | 102.95 ± 3.35 Aa | 106.09 ± 3.59 Aa |
EWN | 95.82 ± 1.23 Aa | 99.96 ± 2.17 Aa | 107.98 ± 2.43 Aa | |
Antioxidant parameters | ||||
 MDA (µM) | Control | 1.28 ± 0.17 Aa | 3.09 ± 0.51 Ab | 1.55 ± 0.34 Aa |
EWN | 1.37 ± 0.15 Aa | 3.13 ± 0.24 Ab | 1.79 ± 0.45 Aa | |
 Thiol (µM) | Control | 659.41 ± 9.18 Aa | 622.01 ± 9.36 Ab | 644.49 ± 8.58 Ab |
EWN | 652.71 ± 7.03 Aa | 606.64 ± 6.99 Ab | 634.90 ± 6.75 Ab | |
 FRAP (mM FeSO4equivalent) | Control | 0.45 ± 0.05 Aa | 0.55 ± 0.04 Ab | 0.65 ± 0.05 Ab |
EWN | 0.48 ± 0.04 Aa | 0.52 ± 0.03 Aa | 0.70 ± 0.04 Ab |